Roche’s Ipatasertib Promising In Prostate, But Disappointing In Breast Cancer
Mixed Results In Pivotal Trials
The ESMO congress had been planned to take place in Madrid this year, but like other meetings, went virtual because of the coronavirus pandemic. 
